Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

No-Scar thyroid surgery tested against traditional neck cut

NCT ID NCT07055191

Symptom relief Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a new surgical technique called TOETVA, which removes the thyroid through the mouth leaving no visible scar, to the standard anterior neck surgery. About 616 adults needing thyroid removal will be randomly assigned to one of the two procedures. The main goal is to see if the new method is as safe as the standard one in terms of early complications like nerve damage or bleeding.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA) - a surgical procedure
What this could lead to
If successful, this could offer patients a thyroid surgery option with no visible neck scar, potentially improving quality of life and reducing stigma.
What could go wrong
This is an early comparative trial, and the new technique is more complex. It may have similar or higher complication rates, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 616 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Nov 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with a surgical indication for lobectomy or thyroidectomy * Estimated thyroid volume measured by ultrasonography of less than 60 mL * Nodules suspected to be malignant measuring less than 4 cm * Patient aged between 18 and 65 years old * Patient who has benefited from an endocrinological evaluation, with a favorable opinion for TOETVA or AC Patient who understands and accepts the need for follow-up * Patient who agrees to be included in the study and who signs the informed consent form * Patient affiliated to a healthcare insurance plan Exclusion Criteria: * Patients refusing an alternative to AC or refusing AC * History of cervical surgery * Associated parathyroid surgery * Identification of malignant lymph nodes * Presence of a severe and evolutive life threatening pathology * Patients with unstable psychiatric disorder, under supervision or guardianship * Patient who does not understand French/ is unable to give consent * Patient not affiliated to a French or European healthcare insurance * Patient who has already been included in a trial which has a conflict of interests with the present study * Pregnant or breast-feeding patient * Patient incarcerated

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lobectomy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lobectomy Thyroidectomy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    10 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AP-HP - Hôpital Avicennes

    NOT_YET_RECRUITING

    Bobigny, France

  • AP-HP - Hôpital Cochin

    NOT_YET_RECRUITING

    Paris, France

  • CHRU de Nancy Brabois

    NOT_YET_RECRUITING

    Vandœuvre-lès-Nancy, France

  • CHU Dupuytren

    NOT_YET_RECRUITING

    Limoges, France

  • CHU de Lille, Hôpital Huriez

    RECRUITING

    Lille, France

  • CHU de Nantes - Hôtel Dieu

    NOT_YET_RECRUITING

    Nantes, France

  • CHU de Poitiers

    NOT_YET_RECRUITING

    Poitiers, France

  • Hôpital Franco-Britannique

    NOT_YET_RECRUITING

    Levallois-Perret, France

  • Hôpital Lyon Sud

    NOT_YET_RECRUITING

    Pierre-Bénite, France

  • Polyclinique de la Côte Basque Sud

    NOT_YET_RECRUITING

    Saint-Jean-de-Luz, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.